Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1105
A. Deb, B. Songtanin, Thanita Thongtan, Sameer R Islam
Collagenous gastritis is a rare cause of heartburn in adults. Histopathological examination of gastric mucosal biopsy from the stomach shows submucosal collagen deposition. The pathophysiologic mechanism is unknown, and collagenous gastritis cases have been associated with certain drugs, such as olmesartan and non-steroidal anti-inflammatory drugs, and certain medical conditions, such as common variable immunodeficiency, primary IgM deficiency, autoimmune disorders, and psoriatic arthropathy. Here we report a case of collagenous gastritis in a 29-year-old woman with psoriatic arthropathy who presented with persistent heartburn. She was successfully treated with oral pantoprazole. Key words: heartburn, collagenous gastritis,
{"title":"Collagenous gastritis presenting as chronic heartburn in a patient with psoriatic arthritis","authors":"A. Deb, B. Songtanin, Thanita Thongtan, Sameer R Islam","doi":"10.12746/swrccc.v10i45.1105","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1105","url":null,"abstract":"Collagenous gastritis is a rare cause of heartburn in adults. Histopathological examination of gastric mucosal biopsy from the stomach shows submucosal collagen deposition. The pathophysiologic mechanism is unknown, and collagenous gastritis cases have been associated with certain drugs, such as olmesartan and non-steroidal anti-inflammatory drugs, and certain medical conditions, such as common variable immunodeficiency, primary IgM deficiency, autoimmune disorders, and psoriatic arthropathy. Here we report a case of collagenous gastritis in a 29-year-old woman with psoriatic arthropathy who presented with persistent heartburn. She was successfully treated with oral pantoprazole. \u0000 \u0000Key words: heartburn, collagenous gastritis,","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75543507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1071
Esere A Nesiama, Rachel Vopni, Nayeli Fuentes, Fiona R. Prabhu, Kelly Bennett
Background Vaccine hesitancy is a public health issue that threatens successful prevention of vaccine-preventable diseases. The Free Clinic at Lubbock Impact serves rural, West Texas uninsured patients. In recognition of low vaccination rates among this population, an initiative was undertaken to better understand factors contributing to COVID-19 vaccine reluctance and conduct interventions to reduce hesitancy. Methodology Patients at the Free Clinic between January 2022 and March 2022 received a voluntary survey regarding their COVID-19 vaccination status, perceived barriers to vaccination, and factors influencing vaccination status with Likert-scale response options. Following the first 3 weeks of data collection, an educational intervention was designed and implemented for unvaccinated participants. The intervention included a motivational interview, pamphlet review, and exit survey to assess future likelihood of vaccination. Results A total of 161 survey responses were obtained from the initial survey with a total unique patient population of 138. Of the 138 unique patients surveyed, 73 reported as vaccinated and 65 reported as not vaccinated against COVID-19. For hesitancy factors among unvaccinated participants, the mode for the “Extremely Important” hesitancy factor was “Personal Preference”. 37 of the 41 unvaccinated participants who received an intervention reported liking the discussion of the COVID-19 vaccine (90.2%), 4 reported they were not interested (9.8%), and 0 reported disliking the intervention. Half of the respondents indicated an increased likelihood of future vaccination. Conclusion The goal of reducing vaccine hesitancy at The Free Clinic was successful. These findings support the benefits of openness to educational interventions among vulnerable populations.
{"title":"Assessing and addressing COVID-19 vaccine hesitancy in a West Texas Free Clinic through motivational interview-guided intervention","authors":"Esere A Nesiama, Rachel Vopni, Nayeli Fuentes, Fiona R. Prabhu, Kelly Bennett","doi":"10.12746/swrccc.v10i45.1071","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1071","url":null,"abstract":"Background \u0000Vaccine hesitancy is a public health issue that threatens successful prevention of vaccine-preventable diseases. The Free Clinic at Lubbock Impact serves rural, West Texas uninsured patients. In recognition of low vaccination rates among this population, an initiative was undertaken to better understand factors contributing to COVID-19 vaccine reluctance and conduct interventions to reduce hesitancy. \u0000Methodology \u0000Patients at the Free Clinic between January 2022 and March 2022 received a voluntary survey regarding their COVID-19 vaccination status, perceived barriers to vaccination, and factors influencing vaccination status with Likert-scale response options. Following the first 3 weeks of data collection, an educational intervention was designed and implemented for unvaccinated participants. The intervention included a motivational interview, pamphlet review, and exit survey to assess future likelihood of vaccination. \u0000Results \u0000 \u0000A total of 161 survey responses were obtained from the initial survey with a total unique patient population of 138. Of the 138 unique patients surveyed, 73 reported as vaccinated and 65 reported as not vaccinated against COVID-19. For hesitancy factors among unvaccinated participants, the mode for the “Extremely Important” hesitancy factor was “Personal Preference”. \u0000 \u000037 of the 41 unvaccinated participants who received an intervention reported liking the discussion of the COVID-19 vaccine (90.2%), 4 reported they were not interested (9.8%), and 0 reported disliking the intervention. Half of the respondents indicated an increased likelihood of future vaccination. \u0000 \u0000Conclusion \u0000The goal of reducing vaccine hesitancy at The Free Clinic was successful. These findings support the benefits of openness to educational interventions among vulnerable populations. \u0000 \u0000 ","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"33 1-2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78186711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1081
D. Paz, Timothy W. Hegeman, Onur Varli, C. Çevik
A 66-year-old male with a history of Marfan syndrome and resolved infective endocarditis was found to have shortness of breath after a previous aortic valve replacement in 2010. Several severe paravalvular leaks were seen on imaging, and left ventricular outflow tract pseudoaneurysms were identified as the cause of his symptoms which warranted treatment. Due to this patient’s risk of surgical intervention, a retrograde transaortic approach was used.
{"title":"Left ventricular outflow tract pseudoaneurysms and severe paravalvular aortic regurgitation treated by percutaneous approach in a Marfan syndrome patient","authors":"D. Paz, Timothy W. Hegeman, Onur Varli, C. Çevik","doi":"10.12746/swrccc.v10i45.1081","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1081","url":null,"abstract":"A 66-year-old male with a history of Marfan syndrome and resolved infective endocarditis was found to have shortness of breath after a previous aortic valve replacement in 2010. Several severe paravalvular leaks were seen on imaging, and left ventricular outflow tract pseudoaneurysms were identified as the cause of his symptoms which warranted treatment. Due to this patient’s risk of surgical intervention, a retrograde transaortic approach was used.","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"254 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91470607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1097
T. Singh, Ricardo Franco, B. Kakarala, Andres Yepes Hurtado
A 56-year-old man with a recent COVID 19 pneumonia presented to the emergency center with cough, hemoptysis, and increasing dyspnea. The patient deteriorated rapidly and was intubated for respiratory failure. Vital signs showed a temperature of 97.8°F, a heart rate of 113 beats/minute, and blood pressure of 107/85 mmHg while on mechanical ventilation. The endotracheal tube was filled with blood. A bedside bronchoscopy showed blood clots in and fresh blood oozing from the right mainstem bronchus. Based on the clinical feature of hemoptysis and a chest radiograph showing right lower and middle lobe consolidation with pleural effusion, the differential diagnosis includes necrotizing pneumonia and alveolar hemorrhage. His history of COVID 19 made pulmonary artery embolism a possibility.
{"title":"COVID-19 induced pulmonary artery aneurysm","authors":"T. Singh, Ricardo Franco, B. Kakarala, Andres Yepes Hurtado","doi":"10.12746/swrccc.v10i45.1097","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1097","url":null,"abstract":"A 56-year-old man with a recent COVID 19 pneumonia presented to the emergency center with cough, hemoptysis, and increasing dyspnea. The patient deteriorated rapidly and was intubated for respiratory failure. Vital signs showed a temperature of 97.8°F, a heart rate of 113 beats/minute, and blood pressure of 107/85 mmHg while on mechanical ventilation. The endotracheal tube was filled with blood. A bedside bronchoscopy showed blood clots in and fresh blood oozing from the right mainstem bronchus. Based on the clinical feature of hemoptysis and a chest radiograph showing right lower and middle lobe consolidation with pleural effusion, the differential diagnosis includes necrotizing pneumonia and alveolar hemorrhage. His history of COVID 19 made pulmonary artery embolism a possibility.","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91533790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1103
Juliana Castaño-Rendón, Sebastián Sánchez López, Andrés Padierna, M. Palácio, Laura Tobon, María Ossa, C. Muriel, Johana Tello, F. Jaimes
Introduction: Approval of generic drugs requires only bioequivalence studies. Some research suggests that generic vancomycin is not clinically equivalent to the branded drug, and this exposes patients to therapeutic failure and the development of microbial resistance. Aims: Compare the rates of microbiological and clinical failure between generic vancomycin and Vancocin-CP®. Methods: Retrospective cohort analysis of hospitalized adults with culture-proven methicillin-resistant Staphylococcus aureus infection, treated with vancomycin in a tertiary care hospital in Medellín, Colombia. General clinical variables, laboratory findings, severity and mortality scores, and type of vancomycin used were recorded. Logistical regression models, adjusted for potential confounders, were fitted to estimate the effect of vancomycin on clinical and microbiologic outcomes. Results: Of 209 patients, 153 (73.2%) received generic vancomycin and 56 (26.8%) Vancocin-CP®. Systems more commonly affected were skin and soft tissues (28.5%), blood with involvement of catheters (27.6%) and blood without the involvement of catheters (23.3%). There were 62 clinical failures (29.5%) and 41(38%) microbiological failures. The hospital mortality rate was 15% (n = 31); only 7 (3.4%) episodes of adverse drug reactions were documented. No difference was found in the risk of clinical or microbiological failure between Vancocin-CP® and generic products with OR = 2.3 (95% CI = 0.8; 6.3) and 0.89 (95% CI = 0.4; 1.9), respectively. Conclusion: There were no association between the use of generic vancomycin and the outcomes of clinical or microbiological failure. Sample size is an important limitation for these findings. Keywords: Vancomycin, bioequivalence, MRSA, clinical equivalence
简介:仿制药的批准只需要生物等效性研究。一些研究表明，仿制万古霉素在临床上并不等同于品牌药，这使患者面临治疗失败和微生物耐药性的发展。目的:比较通用万古霉素和万古霉素- cp®的微生物失败率和临床失败率。方法:回顾性队列分析在哥伦比亚Medellín三级医院接受万古霉素治疗的经培养证实的耐甲氧西林金黄色葡萄球菌感染的住院成人。记录一般临床变量、实验室结果、严重程度和死亡率评分以及使用万古霉素的类型。拟合逻辑回归模型，对潜在混杂因素进行调整，以估计万古霉素对临床和微生物学结果的影响。结果:209例患者中，153例(73.2%)接受通用万古霉素治疗，56例(26.8%)接受万古霉素- cp®治疗。更常受影响的系统是皮肤和软组织(28.5%)、导管受累的血液(27.6%)和未受累的血液(23.3%)。临床失败62例(29.5%)，微生物失败41例(38%)。住院死亡率为15% (n = 31);仅记录了7例(3.4%)药物不良反应。万古霉素- cp®与仿制药在临床或微生物失败风险方面无差异，or = 2.3 (95% CI = 0.8;6.3)和0.89 (95% CI = 0.4;分别为1.9)。结论:通用万古霉素的使用与临床或微生物学失败的结果无相关性。样本量是这些发现的一个重要限制。关键词:万古霉素，生物等效性，MRSA，临床等效性
{"title":"Clinical effectiveness of generic vancomycin products compared to Vancocin CP® in patients with methicillin-resistant Staphylococcus aureus infections: A retrospective cohort","authors":"Juliana Castaño-Rendón, Sebastián Sánchez López, Andrés Padierna, M. Palácio, Laura Tobon, María Ossa, C. Muriel, Johana Tello, F. Jaimes","doi":"10.12746/swrccc.v10i45.1103","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1103","url":null,"abstract":"Introduction: Approval of generic drugs requires only bioequivalence studies. Some research suggests that generic vancomycin is not clinically equivalent to the branded drug, and this exposes patients to therapeutic failure and the development of microbial resistance. \u0000Aims: Compare the rates of microbiological and clinical failure between generic vancomycin and Vancocin-CP®. \u0000Methods: Retrospective cohort analysis of hospitalized adults with culture-proven methicillin-resistant Staphylococcus aureus infection, treated with vancomycin in a tertiary care hospital in Medellín, Colombia. General clinical variables, laboratory findings, severity and mortality scores, and type of vancomycin used were recorded. Logistical regression models, adjusted for potential confounders, were fitted to estimate the effect of vancomycin on clinical and microbiologic outcomes. \u0000Results: Of 209 patients, 153 (73.2%) received generic vancomycin and 56 (26.8%) Vancocin-CP®. Systems more commonly affected were skin and soft tissues (28.5%), blood with involvement of catheters (27.6%) and blood without the involvement of catheters (23.3%). There were 62 clinical failures (29.5%) and 41(38%) microbiological failures. The hospital mortality rate was 15% (n = 31); only 7 (3.4%) episodes of adverse drug reactions were documented. No difference was found in the risk of clinical or microbiological failure between Vancocin-CP® and generic products with OR = 2.3 (95% CI = 0.8; 6.3) and 0.89 (95% CI = 0.4; 1.9), respectively. \u0000Conclusion: There were no association between the use of generic vancomycin and the outcomes of clinical or microbiological failure. Sample size is an important limitation for these findings. \u0000 \u0000Keywords: Vancomycin, bioequivalence, MRSA, clinical equivalence","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75157549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1077
B. Rachman, H. Zuercher, Kristina Jones, Nathan Rachman
The approach for upper extremity surgery brachial plexus blocks depends on the specific nature of the surgery. Interscalene and supraclavicular brachial plexus blocks can cause phrenic nerve palsy. Our aim was to explore the safety of bilateral parasagittal infraclavicular brachial plexus blocks (BPBBs) in an outpatient surgery center. Identical BPBBs were performed in two patients with 20 mL of 0.25% bupivacaine. Neither patient developed respiratory or cardiovascular distress. Brachial plexus blocks on multiple locations are infrequently employed for fear of phrenic nerve paresis. However, given both patients’ success, bilateral parasagittal infraclavicular brachial plexus blocks may provide a safe approach. Keywords: Nerve block, brachial plexus blocks, phrenic nerve, anesthesia, pain
上肢手术臂丛阻滞的入路取决于手术的具体性质。斜角肌间和锁骨上臂丛神经阻滞可引起膈神经麻痹。我们的目的是探讨门诊手术中心双侧侧冠状旁锁骨下臂丛阻滞(BPBBs)的安全性。用20 mL 0.25%布比卡因对两例患者进行相同的BPBBs。两名患者均未出现呼吸或心血管窘迫。由于担心膈神经麻痹，臂丛神经阻滞在多个部位很少使用。然而，鉴于两例患者的成功，双侧侧矢状旁锁骨下臂丛阻滞可能是一种安全的入路。关键词:神经阻滞，臂丛神经阻滞，膈神经，麻醉，疼痛
{"title":"Bilateral infraclavicular brachial plexus nerve blocks in an ambulatory surgery center","authors":"B. Rachman, H. Zuercher, Kristina Jones, Nathan Rachman","doi":"10.12746/swrccc.v10i45.1077","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1077","url":null,"abstract":"The approach for upper extremity surgery brachial plexus blocks depends on the specific nature of the surgery. Interscalene and supraclavicular brachial plexus blocks can cause phrenic nerve palsy. Our aim was to explore the safety of bilateral parasagittal infraclavicular brachial plexus blocks (BPBBs) in an outpatient surgery center. Identical BPBBs were performed in two patients with 20 mL of 0.25% bupivacaine. Neither patient developed respiratory or cardiovascular distress. Brachial plexus blocks on multiple locations are infrequently employed for fear of phrenic nerve paresis. However, given both patients’ success, bilateral parasagittal infraclavicular brachial plexus blocks may provide a safe approach. Keywords: Nerve block, brachial plexus blocks, phrenic nerve, anesthesia, pain","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80166614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1085
A. Sarangi, Dalynn Kim, J. Rafael
The 2020 coronavirus (COVID-19) pandemic has shifted the workplace focus from on-site to remote and has introduced discussions about the positive and negative features of working from home (WFH). Many employees have reported increased control and flexibility regarding one’s schedule with the shift to a remote model. However, there have been increasing concerns regarding the emotional and mental health effects of such a model and the social isolation resulting from staying at home. The lack of professional boundaries, technological limitations, and forced interaction with family members have been considered potentials costs of the convenience of WFH. In this review paper, we discuss the possible benefits and consequences of remote work on various measures of mental health and discuss the implications of future WFH models which may provide workers with greater autonomy and flexibility.
{"title":"The mental health impact of work from home: a literature review","authors":"A. Sarangi, Dalynn Kim, J. Rafael","doi":"10.12746/swrccc.v10i45.1085","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1085","url":null,"abstract":"The 2020 coronavirus (COVID-19) pandemic has shifted the workplace focus from on-site to remote and has introduced discussions about the positive and negative features of working from home (WFH). Many employees have reported increased control and flexibility regarding one’s schedule with the shift to a remote model. However, there have been increasing concerns regarding the emotional and mental health effects of such a model and the social isolation resulting from staying at home. The lack of professional boundaries, technological limitations, and forced interaction with family members have been considered potentials costs of the convenience of WFH. In this review paper, we discuss the possible benefits and consequences of remote work on various measures of mental health and discuss the implications of future WFH models which may provide workers with greater autonomy and flexibility.","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77648732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1043
Benjamin Lee, Christopher Peterson
Artificial Intelligence (AI) and Machine Learning (ML) have advanced rapidly in recent years and now have the potential to change medicine. This review serves as an introduction to AI and the potential it has to change medicine. Specific examples of past milestones particularly in the domain of critical care are presented, including algorithms that have been developed that can interpret chest x-rays or predict clinical outcomes such as extubation failure or ICU mortality. Included is a brief general discussion of what AI is, how it is made, and how physicians will be involved with it. Arguments are then presented as to why AI will likely not leave physicians without a job, including expectations vs. reality, AI still requires human supervision, new discoveries bring new challenges, and AI cannot design itself. Far from displacing physicians, AI, if implemented well, stands poised to automate repetitive tasks, make physicians more accurate, and free them up to spend more time with patients.
{"title":"Machine learning and medicine- a brief introduction","authors":"Benjamin Lee, Christopher Peterson","doi":"10.12746/swrccc.v10i45.1043","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1043","url":null,"abstract":"Artificial Intelligence (AI) and Machine Learning (ML) have advanced rapidly in recent years and now have the potential to change medicine. This review serves as an introduction to AI and the potential it has to change medicine. Specific examples of past milestones particularly in the domain of critical care are presented, including algorithms that have been developed that can interpret chest x-rays or predict clinical outcomes such as extubation failure or ICU mortality. Included is a brief general discussion of what AI is, how it is made, and how physicians will be involved with it. Arguments are then presented as to why AI will likely not leave physicians without a job, including expectations vs. reality, AI still requires human supervision, new discoveries bring new challenges, and AI cannot design itself. Far from displacing physicians, AI, if implemented well, stands poised to automate repetitive tasks, make physicians more accurate, and free them up to spend more time with patients.","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88366070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1065
J. Rahesh, Shazma Khan, A. Siddiqui, R. Jacob
Second cancers occur after the remission of a previous cancer in patients. Due to the increased successful treatment of childhood cancers, these second cancers are more likely to occur for these patients, later in life. Risk factors and causes for these second cancers include predisposing genetic factors, exposure to radiation and chemotherapy from initial cancer treatment, and environmental conditions. The most likely the reason second cancers occur is multifactorial and involves an interaction of both environmental and genetic factors. We present a longitudinal case study following a patient who was treated for an ependymoma at age three and twenty-two years later presenting with symptoms indicative of another cancer, at age 25.
{"title":"Second primary cancer in the brain: a longitudinal case study from childhood into adulthood","authors":"J. Rahesh, Shazma Khan, A. Siddiqui, R. Jacob","doi":"10.12746/swrccc.v10i45.1065","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1065","url":null,"abstract":"Second cancers occur after the remission of a previous cancer in patients. Due to the increased successful treatment of childhood cancers, these second cancers are more likely to occur for these patients, later in life. Risk factors and causes for these second cancers include predisposing genetic factors, exposure to radiation and chemotherapy from initial cancer treatment, and environmental conditions. The most likely the reason second cancers occur is multifactorial and involves an interaction of both environmental and genetic factors. We present a longitudinal case study following a patient who was treated for an ependymoma at age three and twenty-two years later presenting with symptoms indicative of another cancer, at age 25.","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74113502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.12746/swrccc.v10i45.1095
Mahmoud Abdelnabi, Juthipong Benjanuwattra, Sean Lee, S. E. El Nawaa
{"title":"Cephalexin-induced bradycardia in a young healthy woman","authors":"Mahmoud Abdelnabi, Juthipong Benjanuwattra, Sean Lee, S. E. El Nawaa","doi":"10.12746/swrccc.v10i45.1095","DOIUrl":"https://doi.org/10.12746/swrccc.v10i45.1095","url":null,"abstract":"","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"144 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77568396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：